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To sense infection, the innate immune system 
preferentially responds to conserved molecular 
signatures of microbes that are absent from 
normal host cells. There is currently great in-
terest in determining what molecular features 
of pathogens are detected, and how these fea-
tures are sensed by the innate immune system. 
A better understanding of the fundamental 
principles of how immune responses are stimu-
lated is critical for the design of more effective 
vaccines, adjuvants, and immune therapeutics.
One important class of ligands sensed by the 
innate immune system is nucleic acids. Several 
distinct nucleic acid sensors have been described 
and have been found to be distributed to dis-
tinct subcellular locations and exhibit distinct 
specificities for different nucleic acid ligands. A 
common theme is that nucleic acid sensors tend 
to induce expression of type I IFN genes and, 
thus, appear to be particularly important for 
initiating immune responses to viruses.
CORRESPONDENCE  
Sarah M. McWhirter:  
mcwhirt@berkeley.edu  
OR  
Russell E. Vance:  
rvance@berkeley.edu
Abbreviations used: c-di-GMP, 
cyclic-di-GMP; DAI, DNA-
dependent activator of IFN 
regulatory factors; HSA, human 
serum albumin; MEF, mouse 
embryonic fibroblast; TLR, 
Toll-like receptor.
Y. Hayakawa’s present address is Dept. of Applied Chemistry, 
Faculty of Engineering, Aichi Institute of Technology, 
Yakusa, Toyota 470-0392, Japan.
A host type I interferon response is induced 
by cytosolic sensing of the bacterial second 
messenger cyclic-di-GMP
Sarah M. McWhirter,1 Roman Barbalat,1 Kathryn M. Monroe,1  
Mary F. Fontana,1 Mamoru Hyodo,2 Nathalie T. Joncker,1 Ken J. Ishii,3 
Shizuo Akira,3 Marco Colonna,4 Zhijian J. Chen,5 Katherine A. Fitzgerald,6 
Yoshihiro Hayakawa,2 and Russell E. Vance1
1Division of Immunology and Pathogenesis, University of California, Berkeley, Berkeley, CA 94720
2Laboratory of Bioorganic Chemistry, Graduate School of Information Science, Nagoya University, Chikusa,  
Nagoya 464-8601, Japan
3Laboratory of Host Defense, World Premier International Research Center, Immunology Frontier Research Center,  
Osaka University, Suita, Osaka 565-0871, Japan
4Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110
5Howard Hughes Medical Institute, Department of Molecular Biology, University of Texas Southwestern Medical Center,  
Dallas, TX 75390
6Department of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA 01605
The innate immune system responds to unique molecular signatures that are widely con-
served among microbes but that are not normally present in host cells. Compounds that 
stimulate innate immune pathways may be valuable in the design of novel adjuvants, 
vaccines, and other immunotherapeutics. The cyclic dinucleotide cyclic-di–guanosine 
monophosphate (c-di-GMP) is a recently appreciated second messenger that plays critical 
regulatory roles in many species of bacteria but is not produced by eukaryotic cells. In vivo 
and in vitro studies have previously suggested that c-di-GMP is a potent immunostimula-
tory compound recognized by mouse and human cells. We provide evidence that c-di-GMP 
is sensed in the cytosol of mammalian cells via a novel immunosurveillance pathway. The 
potency of cytosolic signaling induced by c-di-GMP is comparable to that induced by 
cytosolic delivery of DNA, and both nucleic acids induce a similar transcriptional profile, 
including triggering of type I interferons and coregulated genes via induction of TBK1, 
IRF3, nuclear factor B, and MAP kinases. However, the cytosolic pathway that senses  
c-di-GMP appears to be distinct from all known nucleic acid–sensing pathways. Our results 
suggest a novel mechanism by which host cells can induce an inflammatory response to a 
widely produced bacterial ligand.
© 2009 McWhirter et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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including Listeria monocytogenes, Mycobacterium tuberculosis, Le-
gionella pneumophila, Francisella tularensis, group B Streptococcus, 
and Brucella abortus, it appears that induction of type I IFN is 
via a novel cytosolic pathway and is independent of TLRs. It 
has been suggested that these pathogens trigger the cytosolic 
DNA-sensing pathway, but neither the host sensors nor the 
bacterial ligands that trigger cytosolic induction of type I IFNs 
by these pathogens have been identified. Intriguingly, evidence 
from L. monocytogenes suggests that bacterial multidrug efflux 
pumps are required for induction of type I IFN (Crimmins   
et al., 2008), and raises the possibility that a small molecule 
substrate of these pumps, rather than DNA, is the bacterial 
trigger of type I IFN gene expression.
Nucleotide second messengers are critical transmitters of 
signaling in all living things. cAMP is used by bacteria and eu-
karyotes alike, whereas certain nucleotide second messengers   
are unique to bacteria. For example, guanosine tetraphosphate 
(ppGpp) is a key regulator of the stringent response in bac-
teria (Srivatsan and Wang, 2008). Another nucleotide sec-
ond messenger, cyclic-di-GMP (c-di-GMP), is a relatively 
recently appreciated cyclic ribonucleotide (Ross et al., 1987) 
synthesized by bacteria from two GTP precursors that are 
hydrolyzed and ultimately circularized via 5-to-3 mono-
phosphate linkages. The bacterial diguanylate cyclases that 
synthesize c-di-GMP all contain a characteristic GGDEF do-
main, whereas the phosphodiesterases that specifically degrade 
c-di-GMP to pGpG contain an EAL domain. The GGDEF 
domain, and presumably c-di-GMP, appears to be limited to 
Bacteria (Galperin et al., 2001) and is not found in Archaea 
or Eukarya. c-di-GMP appears to play complex roles as a 
second messenger in most bacterial species, and regulates di-
verse processes, such as motility, biofilm formation, and viru-
lence gene expression (Tamayo et al., 2007). The molecular 
mechanisms by which c-di-GMP regulates these biological 
processes in bacteria are only beginning to be understood. It 
appears that c-di-GMP is capable of specific binding to regu-
latory proteins containing the PilZ protein domain (Cotter 
and Stibitz, 2007). The PelD protein of P. aeruginosa is an ad-
ditional non-PilZ–containing c-di-GMP sensor protein (Lee 
et al., 2007).
Several recent reports have suggested that c-di-GMP can 
stimulate a variety of signaling pathways in mammalian cells 
in vivo. One early report demonstrated that 50 µM of exoge-
nous c-di-GMP inhibited growth of human colon cancer 
cells (Karaolis et al., 2005a) without toxicity against normal 
kidney cells. Two additional reports have indicated that c-di-
GMP can function as an adjuvant. One group demonstrated 
a highly significant (>200-fold; P < 0.001) induction of anti-
ClfA IgG2a titers when mice were vaccinated with ClfA and 
c-di-GMP as compared with vaccination with ClfA alone 
(Karaolis et al., 2007a). Another group found a similar induc-
tion of anti–-Gal titers when c-di-GMP was used as an ad-
juvant (Ebensen et al., 2007). Both groups also found increased 
T cell responses in mice injected with c-di-GMP. Karoalis   
et al. (2007a) also showed that c-di-GMP has immunostimu-
latory effects in vivo and in vitro on innate cell populations, 
Toll-like receptor (TLR) 3, 7, 8, and 9 are transmem-
brane  nucleic  acid  receptors  that  reside  in  intracellular 
compartments, where they detect endocytosed or autopha-
gocytosed nucleic acids (Kawai and Akira, 2007; Medzhitov, 
2007). TLR7, 8, and 9 all require the signaling adaptor 
MyD88 to initiate downstream signaling, whereas TLR3 re-
quires the signaling adaptor TRIF. Thus, MyD88/Trif / 
double-knockout cells are deficient in signaling through all 
known TLRs that sense nucleic acids (Hoebe et al., 2003; 
Yamamoto et al., 2003).
Interestingly, recent work has established that MyD88/ 
Trif / cells are capable of responding to nucleic acid ligands 
via cytosolic immunosurveillance pathways. Cytosolic RNA 
appears to be sensed by two RNA helicase–containing pro-
teins, RIG-I and Mda5 (Yoneyama et al., 2004). Interestingly, 
RIG-I and Mda5 do not perform redundant functions and 
appear to respond to distinct classes of viruses (Gitlin et al., 
2006; Hornung et al., 2006; Kato et al., 2006; Pichlmair   
et al., 2006; Saito and Gale, 2008). Signaling by RIG-I and 
Mda5 requires a common adaptor molecule called MAVS 
(also known as IPS-1, Cardif, or VISA; Kawai et al., 2005; 
Meylan et al., 2005; Seth et al., 2005; Xu et al., 2005; Sun 
et al., 2006). MAVS recruits the TBK1 kinase that phos-
phorylates and activates the IRF3 transcription factor. Other 
transcription factors such as ATF2/c-Jun and NK-B form a 
coordinated DNA-bound complex with IRF3, and are to-
gether required for robust activation of the IFN- promoter 
(Maniatis et al., 1998; Panne, 2008).
Many cell types also appear to respond to the cytosolic 
presence of DNA (Ishii et al., 2006; Stetson and Medzhitov, 
2006a). The cytosolic response to DNA does not require 
MAVS, but does require TBK1 and IRF3 in most cell types 
(Ishii et al., 2006; Stetson and Medzhitov, 2006a; Sun et al., 
2006). Recently, a putative cytosolic sensor of DNA was 
identified, and was named DNA-dependent activator of IFN 
regulatory factors (DAI; previously known as DLM-1 or 
ZBP1; Takaoka et al., 2007). Knockdown experiments indi-
cated that DAI was involved in sensing cytosolic DNA in the 
L929  fibroblast-like  and  RAW  macrophage-like  cell  lines 
(Takaoka et al., 2007; Wang et al., 2008). DAI was expressed 
in other cell types, such as mouse embryonic fibroblasts 
(MEFs), but was dispensable for the response to cytosolic 
DNA in these cell types, suggesting that additional uncharac-
terized nucleic acid sensor proteins also exist (Wang et al., 
2008). Indeed, cells from DAI knockouts appear to respond 
normally to cytosolic DNA (Ishii et al., 2008), possibly be-
cause of redundancy with other cytosolic DNA sensors.
Although type I IFNs are primarily considered to be anti-
viral cytokines (Stetson and Medzhitov, 2006b), there is 
growing appreciation for their complex role in bacterial in-
fections as well. Indeed, it is clear that type I IFNs are induced 
by many, if not all, bacterial pathogens, and can contribute to 
diverse outcomes in vivo (Coers et al., 2000; O’Riordan   
et al., 2002; Opitz et al., 2006; Stetson and Medzhitov, 2006a; 
Henry et al., 2007; Roux et al., 2007; Stanley et al., 2007; 
Charrel-Dennis et al., 2008). For several bacterial pathogens, JEM VOL. 206, August 31, 2009 
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(a) the c-di-GMP compound was chemically synthesized and 
>98% pure by HPLC (not depicted), (b) phosphodiesterase 
treatment of c-di-GMP resulted in a product that is no longer 
stimulatory (Fig. 1 E), and (c) macrophages deficient in all 
TLR signaling and unable to respond to LPS still responded 
to c-di-GMP (see below). Thus, these observations suggest 
that c-di-GMP is sensed in the cytosol, resulting in a potent 
induction of type I IFN in bone marrow macrophages.
Cytosolic c-di-GMP and DNA induce similar  
transcriptional responses
We performed microarray experiments to compare the global 
transcriptional response induced by cytosolic c-di-GMP with 
that induced by cytosolic DNA (Fig. 1 F and Table S1). Whole 
transcriptome spotted MEEBO microarrays (Verdugo and 
Medrano, 2006) were used in these experiments. The results 
indicated that the transcriptional profile of cells stimulated by 
cytosolic c-di-GMP was very similar to the transcriptional 
profile of cells stimulated with cytosolic DNA. Induction of 
type I IFNs and known type I IFN-inducible genes domi-
nated the transcriptional response, but other genes (e.g., Il6, 
Cd86, and Cxcl9) were also strongly induced (Fig. 1 F and 
Table S1). Although the transcriptional profiles of cells stimu-
lated with c-di-GMP and DNA were highly similar, a small 
number of genes were reproducibly preferentially induced by 
c-di-GMP as compared with DNA (e.g., HtrA serine pepti-
dase 4 and claudin 23; Table S1). Collectively, these results 
suggested that similar but not identical downstream signaling 
pathways are triggered by DNA and c-di-GMP.
Cytosolic c-di-GMP signals independently of TLRs  
but requires TBK1 and IRF3
It was previously reported that HEK293 cells stably transfected 
with various TLRs failed to respond to c-di-GMP (Karaolis   
et al., 2007a), but the reason for this failure was unclear. For 
example, HEK293 cells might lack an essential accessory pro-
tein. To rule out a role for TLRs in sensing of c-di-GMP, we 
tested responses in Myd88/Trif /double-knockout mac-
rophages, which are deficient in all TLR signaling (Yamamoto 
et al., 2003). Both wild-type and Myd88/Trif / macro-
phages showed a robust induction of IFN- after c-di-GMP 
stimulation (Fig. 2 A). As expected, the Myd88/Trif / 
macrophages did not respond to LPS (Fig. 2 A). These results 
indicated that TLR signaling is not required for responsiveness 
to c-di-GMP, and are consistent with c-di-GMP signaling via 
a cytosolic surveillance pathway.
Robust transcription of the IFN- gene requires the co-
ordinate activation of several transcription factors, including 
IRF3 and NF-B (Panne, 2008). We therefore expected that 
the c-di-GMP–induced signaling pathway would also require 
these factors to induce type I IFN. IRF3 activation requires 
phosphorylation by the TBK1 kinase, which leads to IRF3 
dimerization and nuclear translocation (Fitzgerald et al., 2003; 
Sharma et al., 2003; Hemmi et al., 2004; McWhirter et al., 
2004; Perry et al., 2004). To address whether TBK1 is re-
quired for activation of type I IFN by c-di-GMP, we tested 
including monocytes, macrophages, and granulocytes. c-di-
GMP induced dendritic cell maturation and led to the pro-
duction of various cytokines and chemokines, including TNF, 
IL-1, IP-10, Rantes, and CXCR4 (Karaolis et al., 2007a). 
However, c-di-GMP did not stimulate induction of type I 
IFNs by plasmacytoid dendritic cells. Impressively, preinjec-
tion of 2.5 mg/kg c-di-GMP protected against subsequent 
lethal challenge with Klebsiella pneumoniae or Staphlyococcus 
aureus (Karaolis et al., 2005b; Karaolis et al., 2007b). Despite 
the impressive in vivo biological effects of c-di-GMP, the 
mechanism by which c-di-GMP stimulates host immunity 
remains unknown.
In this study, we provide evidence that mammalian cells 
survey their cytosol for the presence of c-di-GMP. We find 
that c-di-GMP triggers a transcriptional response virtually in-
distinguishable from the response triggered by cytosolic 
DNA. Like the response to DNA, the response to c-di-GMP 
requires  the  TBK1  kinase  and  IRF3  transcription  factor. 
However, the pathway for sensing c-di-GMP can be distin-
guished from that for sensing DNA in certain cell types and, 
moreover, appears to be distinct from all other known cyto-
solic sensing pathways. Our results suggest a novel mecha-
nism by which host cells can induce an inflammatory response 
to a widely produced bacterial ligand.
RESULTS
Cytosolic recognition of c-di-GMP leads to potent induction 
of type I IFN
We hypothesized that c-di-GMP might be sensed by a cyto-
solic sensor leading to the induction of type I IFNs. To test 
this hypothesis, we compared the ability of overlayed versus 
transfected c-di-GMP to induce type I IFN in bone marrow 
macrophages. At the concentrations used (up to 25 µg/ml), 
overlay of c-di-GMP did not elicit a significant response   
(Fig. 1 A), although IFN- production could be detected at 
higher concentrations (50 or 100 µg/ml; not depicted). In 
contrast, delivery of c-di-GMP to the cytosol by transfection 
elicited robust activation of IFN- in a dose-dependent man-
ner (Fig. 1 A). A significant response was detected with a 
concentration of c-di-GMP as low as 2.5 µg/ml (equivalent 
to 3.6 µM). These results suggested that c-di-GMP signals via 
a cytosolic immunosurveillance pathway.
We tested whether compounds related to c-di-GMP were 
capable of stimulating IFN- expression when delivered to 
the cytosol. We measured induction of endogenous type I 
IFN protein by bioassay (Fig. 1 B), and induction of IFN- 
and IFN-5 mRNA levels by quantitative RT-PCR (Fig. 1, 
C and D). No detectable IFN- production was observed 
upon transfection with GTP, cGMP, ppGpp (a different bac-
terial nucleotide second messenger), or pGpG (hydrolyzed 
c-di-GMP), whereas the cytosolic response to 3.3 µg/ml of 
transfected c-di-GMP was of a similar magnitude to that of   
3.3 µg/ml of transfected DNA (pdA:dT) and RNA (pI:C), which 
are known cytosolic inducers of type I IFN. We do not be-
lieve that the cytosolic induction of type I IFNs in response to 
c-di-GMP is caused by a contaminant (such as LPS) because 1902 CYTOSOLIC SENSING OF cyclic-di-GMP | McWhirter et al.
a role in IFN-–mediated antiviral immunity (Tenoever et al., 
2007), and found that Ikbke/ macrophages responded nor-
mally to c-di-GMP (Fig. 2 C).
To examine the role of IRF3 in c-di-GMP induction   
of IFN-, we tested the ability of c-di-GMP to induce signal-
ing in macrophages lacking Irf3. We observed that Irf3/ 
macrophages failed to induce IFN- in response to c-di-GMP 
(Fig. 2 D). We also tested Irf7/ macrophages and observed 
a partial requirement for IRF7 by the c-di-GMP pathway 
(Fig. 2 D). Loss of Irf7 is likely compensated for by Irf3 in 
macrophages. The partial requirement for Irf7 may reflect a 
c-di-GMP responses in Tbk1/ macrophages (Fig. 2 B). We 
observed very little IFN- induction by c-di-GMP in cells 
lacking  Tbk1,  suggesting  that  TBK1  is  required  for  c-di-
GMP signaling. We also observed that Tbk1 is required for 
the induction of IFN- by pdA:dT (Fig. 2 B), in agreement 
with a recently published report (Miyahira et al., 2009). Al-
though the data indicate a key role for Tbk1 in the response 
to  c-di-GMP,  it  is  formally  possible,  albeit  unlikely,  that 
Tbk1 protein rather than Tbk1 kinase activity is required for 
the response. We also tested the requirement for the TBK1-
related kinase Ikbke (also called IKK or IKK-i), which plays 
Figure 1.  c-di-GMP is a potent cytosolic inducer of type I IFNs. (A) Bone marrow macrophages were overlaid or transfected with the indicated 
amounts of synthetic, purified c-di-GMP. The amount of type I IFN in the supernatant was assessed after 6 h by use of an L929-ISRE-luc bioassay (Jiang 
et al., 2005) using recombinant IFN- as a standard. *, P < 0.01 as compared with transfected c-di-GMP (Student’s t test). (B) Bone marrow macrophages 
were transfected with 3.3 µg/ml of the indicated molecules (or overlaid with 100 ng/ml LPS), and type I IFN was assessed after 6 h by bioassay as in A.  
*, P < 0.001 as compared with unstimulated cells (Student’s t test). (C) Bone marrow macrophages were transfected with 3.3 µg/ml of the indicated molecules 
(or overlaid with 100 ng/ml LPS), and transcription of the IFN- gene (Ifnb) was assessed by quantitative RT-PCR, with normalization to ribosomal protein 
rps17 message. n.d., not detectably induced above background (lipofectamine alone). *, P < 0.001 as compared with unstimulated cells (Student’s t test). 
(D) As in C, but transcription of the IFN-5 gene was assessed. n.d., not detectably induced above background (lipofectamine alone). *, P < 0.01 as com-
pared with unstimulated cells (Student’s t test). (E) c-di-GMP, treated or untreated with snake venom phosphodiesterase, was transfected at 3.3 µg/ml 
into B6 bone marrow macrophages and analyzed after 6 h for IFN- production by bioassay, as in A. *, P < 0.02 as compared with c-di-GMP treatment 
alone (Student’s t test). Results in A–E are representative of at least three independent experiments. Data are means ± SD (n = 3). (F) Bone marrow mac-
rophages were transfected with poly dA:dT (DNA) or with c-di-GMP. Total RNA was isolated after 6 h of stimulation. Probes were amplified and hybridized 
to whole-transcriptome spotted MEEBO microarrays. Each dot represents a single gene, and its position is determined by its induction in response to DNA 
(x axis) or c-di-GMP (y axis). Most genes lie on the diagonal, indicative of similar induction ratios by both treatments. Selected highly induced genes are 
labeled. Two independent microarray experiments gave similar results.JEM VOL. 206, August 31, 2009 
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transcription factors, as well as phosphorylation of the p38, 
JNK, and ERK MAP kinases, in response to c-di-GMP. Ac-
tivation of IRF3 involves phosphorylation, dimerization, and 
translocation into the nucleus. We tested whether treatment 
with c-di-GMP resulted in significant nuclear accumulation 
of IRF3. As expected, we found that c-di-GMP resulted in 
significant translocation of IRF3 to the nucleus (Fig. 3 A).
We also tested whether transfected c-di-GMP is capable 
of activating NF-B. This was particularly important to es-
tablish in light of a previous report that exogenous (untrans-
fected) c-di-GMP failed to activate NF-B (Karaolis et al., 
2007a). There have also been inconsistent reports in the lit-
erature as to whether cytosolic DNA induces NF-B (Ishii   
et al., 2006; Stetson and Medzhitov, 2006a; Sun et al., 2006). 
We found that c-di-GMP treatment led to the activation of 
NF-B, as assessed by using an electromobility gel shift assay, 
with similar kinetics to that of transfected pI:C and pdA:dT 
(Fig.  3  B).  The  probe-bound  complex  was  confirmed  to 
contain NF-B p65 by supershifting with an anti-p65 anti-
body (Fig. 3 B). We confirmed these results by using a RAW 
role for Irf7 signaling as part of a positive feedback loop 
involving signaling through the type I IFN receptor (Ifnar). 
Indeed, Ifnar/ macrophages exhibited a diminished response to 
c-di-GMP (Fig. 2 E). Irf5 and Irf1 did not seem to be required 
for responsiveness to c-di-GMP (Fig. 2 F). In addition, macro-
phages deficient in Rip2, Nalp3, or doubly deficient in Nod1/2 
responded normally to c-di-GMP (unpublished data).
We validated our results by examining production of a 
second secreted molecule known to be a target of the Tbk1–
Irf3 signaling axis, the chemokine Rantes (Ccl5). Rantes 
production was assessed by ELISA (Fig. S1). As expected, we 
found that Rantes was induced by c-di-GMP in a manner 
dependent on Tbk1, Irf3, and Ifnar, but largely or entirely in-
dependent of MyD88/Trif, Irf1, Irf5, Irf7, or Mavs (Fig. S1).
c-di-GMP activates IRF3, NF-B, and MAP kinases
Our genetic data suggested that the cytosolic responses to 
DNA, RNA, and c-di-GMP share a common downstream 
signaling pathway. If this were true, we would expect to be 
able to detect biochemical activation of the NF-B and IRF3 
Figure 2.  Induction of type I IFN by c-di-GMP is independent of TLRs and requires TBK1 and IRF3. (A) Bone marrow macrophages from 
Myd88/Trif/ mice were transfected with 3.3 µg/ml c-di-GMP or pdA:dT (DNA), or overlayed with 100 ng/ml LPS as indicated. After 6 h of stimulation, 
induction of IFN- mRNA was analyzed by quantitative RT-PCR, with normalization to ribosomal protein rps17 message. n.d., not detectable. (B) As in A, 
except Tnfr1/ or Tnfr1/Tbk1/ macrophages were analyzed. Tbk1 deficiency is embryonic lethal, but viability can be rescued on the TNF receptor 1 
(Tnfr1)–deficient background. (C) As in A except Ikbke (IKK/IKK-i)-deficient mice were analyzed. (D) as in A, except Irf3/ and Irf7/ macrophages were 
analyzed. (E) as in A, except macrophages deficient in the type I IFN receptor (Ifnar/) were analyzed. (F) as in A, except Irf5/ and Irf1/ macrophages 
were analyzed. Results are representative of at least three independent experiments. Data are means ± SD (n = 3). *, P < 0.05; and **, P < 0.001 as com-
pared with wild-type bone marrow macrophages (Student’s t test).1904 CYTOSOLIC SENSING OF cyclic-di-GMP | McWhirter et al.
discrepancy between our results and those of Karaolis et al. 
(2007a), it is more likely that we were able to detect MAP 
kinase activation because transfection of c-di-GMP triggers 
more robust responses than overlayed c-di-GMP, and be-
cause we examined later time points.
Cell type–specific responses to cytosolic DNA and c-di-GMP
Collectively, these results suggest that there are strong simi-
larities in the signaling pathways triggered by the cytosolic 
presence of c-di-GMP and other nucleic acids, such as DNA 
and RNA. However, c-di-GMP is not structurally similar to 
these nucleic acid ligands. The DNA molecules capable of 
provoking cytosolic responses are double stranded and >25 
deoxyribonucleotides in length (Ishii et al., 2006; Stetson and 
Medzhitov, 2006a). In contrast, c-di-GMP is composed of 
two guanosine ribonucleotides (not deoxyribonucleotides) in 
an unusual cyclic conformation. c-di-GMP also lacks features 
consistent with recognition by RIG-I or Mda5, such as 5-
triphosphate, polyuridine, or double strandedness (Saito and 
Gale, 2008; Saito et al., 2008). Therefore, we considered 
whether distinct sensors might be responsible for triggering 
responses to DNA/RNA and c-di-GMP, and if so, whether 
the responses could be distinguished in certain cell types.
macrophage cell line stably transfected with an NF-B lucif-
erase reporter. We observed activation of the NF-B lucifer-
ase reporter by transfected c-di-GMP (Fig. 3 C). Both the gel 
shift and reporter assays showed that the activation of NF-B 
by transfected c-di-GMP was not as strong as observed with 
transfected pdA:dT and pI:C. The subtle difference in NF-B 
induction between cytosolic DNA and c-di-GMP may sug-
gest that there are distinct signaling components upstream of 
NF-B in the two pathways. Nonetheless, we concluded 
that transfected c-di-GMP is capable of activating NF-B. 
The relatively low levels and late time course of NF-B in-
duction by c-di-GMP (as compared with induction by LPS), 
as well as the fact that we transfected c-di-GMP into cells, 
may explain why NF-B induction was not previously ob-
served in response to c-di-GMP (Karaolis et al., 2007a).
We also tested whether MAP kinase pathways are acti-
vated by c-di-GMP. A previous report found that overlay 
of c-di-GMP induced ERK but not p38 in human macro-
phages (Karaolis et al., 2007a). In contrast, we found that 
cytosolic c-di-GMP stimulated p38, ERK1/2, and JNK 
phosphorylation in mouse bone marrow macrophages trans-
fected with c-di-GMP (Fig. 3 D). Although a difference 
between human and mouse macrophages may explain the 
Figure 3.  The host transcription factors IRF3 and NF-B are induced by c-di-GMP, as are the p38, JNK, and ERK1/2 MAP kinases.  
(A) Nuclear extracts from Myd88/Trif/ macrophages stimulated for the indicated times with c-di-GMP, poly dA:dT (pdA:dT, DNA), or poly I:C (pI:C, RNA) 
were probed with the indicated antibodies. (B) Nuclear extracts from Myd88/Trif/ macrophages stimulated with c-di-GMP, poly dA:dT (pdA:dT, DNA), 
or poly I:C (pI:C, RNA) for the indicated times were used in a gel shift assay with an NF-B consensus binding sequence probe. (C) RAW264.7 macro-
phages stably expressing an NF-B luciferase reporter were stimulated with c-di-GMP, poly dA:dT (pdA:dT, DNA), or poly I:C (pI:C, RNA) for 6 h and 
analyzed for luciferase activity. (D) Whole-cell extracts from Myd88/Trif/ macrophages stimulated for the indicated times with c-di-GMP, poly dA:dT 
(pdA:dT, DNA), or poly I:C (pI:C, RNA) were probed with the indicated antibodies. Results are representative of at least three independent experiments. 
Data are means ± SD (n = 3). *, P < 0.05 compared with unstimulated cells (Student’s t test).JEM VOL. 206, August 31, 2009 
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tion, and is downstream of two cytosolic viral RNA sensors, 
RIG-I and Mda5 (Sun et al., 2006). To test if c-di-GMP sig-
nals through the cytosolic RNA-sensing pathway, we tested 
c-di-GMP responses in Mavs/ and Mda5/ macrophages. 
Loss of Mavs or Mda5 did not affect the induction of IFN- 
by c-di-GMP (Fig. 5, A and B; and Fig. S1 C), suggesting 
that c-di-GMP does not signal through the cytosolic RNA 
signaling apparatus (Gitlin et al., 2006; Kato et al., 2008; 
Saito and Gale, 2008).
DAI (encoded by the Zpb1 gene) is a recently identified 
molecule that has been proposed to function as a sensor of 
cytosolic DNA (Takaoka et al., 2007; Wang et al., 2008). We 
found that bone marrow–derived macrophages from Zbp1-
deficient mice (Ishii et al., 2008) still responded to c-di-GMP 
(Fig.  5  C).  However,  as  previously  reported  (Ishii  et  al., 
2008), Zbp1-deficient macrophages also responded normally 
to DNA (Fig. 5 C). These results imply that macrophages 
express at least one cytosolic DNA sensor that is distinct from 
In addition to bone marrow macrophages, we observed 
induction of IFN- by cytosolic c-di-GMP in a variety of 
other cell types, including peritoneal macrophages, conven-
tional dendritic cells, L929 cells, and RAW 264.7 macro-
phages (Fig. 4, A–D). These cells also responded to transfected 
DNA and RNA. Interestingly, however, we were unable to 
detect significant induction of type I IFNs by c-di-GMP in 
MEFs or in 293T cells, even though the cytosolic pathways 
for detecting DNA and RNA are intact in these cells (Fig. 4, 
E and F). These results suggest that at least one component of 
the host signaling pathway responding to c-di-GMP is dis-
tinct from that used for responses to cytosolic RNA or DNA, 
and is differentially expressed in different cell types.
Known DNA and RNA sensing pathways are not required  
for responses to c-di-GMP
MAVS (also known as IPS-1) is an essential adapter protein 
in the cytosolic RNA pathway leading to type I IFN induc-
Figure 4.  Responsiveness to cytosolic c-di-GMP varies among cell types and does not correlate with responsiveness to cytosolic DNA or 
RNA. (A) Thioglycollate-elicited peritoneal macrophages were stimulated with 3.3 µg/ml c-di-GMP, poly dA:dT (pdA:dT, DNA), or poly I:C (pI:C, RNA), and 
type I IFN was measured by bioassay as in Fig. 1 A. (B) GM-CSF–differentiated dendritic cells were stimulated as in A. SeV, Sendai virus. (C) L929 cells were 
stimulated as in A. (D) RAW264.7 macrophage-like cells were stimulated as in A. (E) MEFs were stimulated as in A. (F) 293T cells were stimulated as in A. In 
B, D, and F, induction of IFN- transcripts was assessed by quantitative RT-PCR. Results are representative of at least three independent experiments. 
Data are means ± SD (n = 3). n.d., not detectable. *, P < 0.01; and **, P < 0.001 as compared with unstimulated cells (Student’s t test).1906 CYTOSOLIC SENSING OF cyclic-di-GMP | McWhirter et al.
and measured their responsiveness to YAC-1 target cells ex 
vivo. Because NK cells respond to in vivo injection of poly 
I:C, a prototypical IFN inducer, we expected that c-di-GMP 
might also activate NK cells. Indeed, NK cells obtained from 
B6 mice injected with c-di-GMP responded to YAC-1 cells, 
as  measured  by  intracellular  cytokine  staining  for  IFN- 
(Fig. 6 B). However, NK cells obtained from Irf3/7/ mice 
stimulated with c-di-GMP were nonresponsive to YAC-1 
target cells. As a negative control, NK cells stimulated ex 
vivo with PBS did not produce IFN-. These observations 
indicate that c-di-GMP can stimulate cytokine and NK cell 
responses in vivo, and these responses require the IRF3/7 
transcription factors.
To obtain a preliminary indication as to whether adaptive 
immune responses could be stimulated by c-di-GMP, we im-
munized mice with human serum albumin (HSA) and tested 
whether coinjected c-di-GMP could function as an adjuvant, 
as previously reported (Ebensen et al., 2007; Karaolis et al., 
DAI, and at least one of these uncharacterized DNA sensors, 
or another independent sensor, may respond to c-di-GMP.
c-di-GMP signals through IRF3 and IRF7 in vivo
To validate our findings in vivo, we injected mice intraperi-
toneally with c-di-GMP (200 nmol per mouse) and mea-
sured the production of type I IFNs in the blood 18 h later. 
B6 mice injected with c-di-GMP produced an IFN response 
to c-di-GMP, and this response was abolished in Irf3/7 
double-deficient mice (Fig. 6 A). Interestingly, single-defi-
cient Irf3/ mice responded to c-di-GMP in vivo (unpub-
lished  data),  implying  a  role  for  IRF7  in  responses  to 
c-di-GMP in vivo. To determine whether cytokine induc-
tion by c-di-GMP affected cellular responses in vivo, we 
collected splenic NK cells from mice injected with c-di-GMP 
Figure 5.  c-di-GMP does not stimulate known cytosolic path-
ways for sensing nucleic acids. (A) Mavs/ and littermate wild-type 
macrophages were transfected with 3.3 µg/ml c-di-GMP, poly dA:dT 
(pdA:dT, DNA), or poly I:C (pI:C, RNA), and transcription of the IFN- 
gene (Ifnb) was assessed by quantitative RT-PCR, with normalization to 
ribosomal protein rps17 message. n.d., not detectable. (B) Mda5/ and 
wild-type control macrophages were stimulated and analyzed as in A. 
(C) Zbp1/ (DAI knockout) and wild-type control macrophages were 
stimulated and analyzed as in A. SeV, Sendai virus. Results are represen-
tative of at least three independent experiments. Data are means ± SD 
(n = 3). *, P < 0.01; and **, P < 0.001 as compared with wild-type bone 
marrow macrophages (Student’s t test).
Figure 6.  c-di-GMP activates IRF3/7-dependent responses in vivo. 
(A and B) B6 and Irf3/7/ mice were injected intraperitoneally with 200 
nmol c-di-GMP, and (A) serum IFN was measured by bioassay 18h later, or 
(B) 36 h after injection, splenic NK responsiveness to YAC-1 target cells (or 
PBS control) was measured ex vivo by intracellular staining for IFN-.  
(C) B6 and Irf3/7/ mice were injected intraperitoneally with HSA ± 200 nmol 
c-di-GMP, and 2 wk later serum IgG1 specific for HSA was determined by 
ELISA. The experiments in A and B were repeated twice, and the experiment 
in C was performed once. Horizontal bars represent means. **, P < 0.01; 
and *, P < 0.05 (Student’s t test).JEM VOL. 206, August 31, 2009 
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respond well to c-di-GMP. Given the marked chemical dis-
similarities among DNA, RNA, and c-di-GMP, it is perhaps 
not surprising that these nucleic acids appear to be recognized 
by different sensors. Indeed, we favor the idea that there are 
multiple cytosolic sensors for nucleic acids leading to induc-
tion of type I IFNs. The specificities of these various sensors 
will require further dissection. For example, although DAI 
knockout cells still responded to c-di-GMP, it remains for-
mally possible that DAI is just one of several redundant sen-
sors for c-di-GMP. These possibilities can be addressed once 
additional cytosolic nucleic acid sensors are identified.
Our results suggest that cytosolic sensing of c-di-GMP is 
relatively specific. Other related small nucleic acid compounds 
such as GTP, cGMP, ppGpp, and pGpG did not trigger tran-
scriptional induction of type I IFNs (Fig. 1). In addition, c-di-
GMP that was hydrolyzed by snake venom phosphodiesterase 
did not induce type I IFN (Fig. 1). However, our results can-
not eliminate the possibility that a metabolite of c-di-GMP, 
rather than c-di-GMP itself, is the true molecular moiety that 
is sensed in the cytosol. Elimination of this possibility awaits 
identification of the c-di-GMP sensor and biophysical or 
crystallographic characterization of its binding to c-di-GMP. 
Our results also cannot eliminate the possibility that c-di-GMP 
triggers  type  I  IFN  expression  indirectly,  for  example,  by 
stimulating the synthesis of a host ligand that functions as the 
“true” proximal trigger of type I IFN gene expression. It is 
also possible that c-di-GMP acts “pharmacologically” by dis-
rupting host physiology in a way that results in type I IFN ex-
pression. Moreover, because the signaling triggered by c-di-GMP 
and cytosolic DNA are very similar, it is possible that the c-di-
GMP pathway is a branch off of the DNA-sensing pathway 
rather than a fully independent pathway. However, even if 
these alternative models are correct, our data indicate that the 
pathway  downstream  of  c-di-GMP  contains  at  least  some 
novel  components  and  is  at  least  partially  independent  of 
known cytosolic or TLR signaling pathways.
Several bacterial pathogens, including L. monocytogenes,   
L. pneumophila, F. tularensis, M. tuberculosis, and group B 
Streptococcus, have been reported to induce type I IFNs (Coers 
et al., 2000; O’Riordan et al., 2002; Opitz et al., 2006; Stetson 
and Medzhitov, 2006a; Henry et al., 2007; Roux et al., 2007; 
Stanley et al., 2007; Charrel-Dennis et al., 2008). The mech-
anism by which these pathogens induce type I IFN resembles 
that of c-di-GMP: in all cases, type I IFN induction is inde-
pendent of MyD88/Trif and TLRs, requires TBK1 and IRF3, 
and (with one exception; unpublished data; Opitz et al., 2006) 
is independent of the cytosolic RNA-sensing pathway. It is 
widely assumed that bacterial DNA, perhaps released after 
bacterial cell lysis, is the relevant ligand that triggers type I 
IFNs in response to pathogens. There are no data that eliminate 
or confirm this possibility, as sensors required for IFN induc-
tion in response to cytosolic bacteria have not yet been re-
ported. However, it is noteworthy that in all cases, induction 
of type I IFNs by cytosolic bacteria requires expression of   
an auxiliary secretion system, namely the ESX-1 system of   
M.  tuberculosis,  the  Francisella  pathogenicity  island-encoded   
2007a). Serum was collected from immunized mice 2 wk 
after a single intraperitoneal injection. Mice immunized with 
HSA alone did not mount a significant antibody response to 
HSA. In contrast, mice injected with HSA plus c-di-GMP 
produced variable but significant titers of HSA-specific IgG1 
antibodies, confirming that c-di-GMP can function as an ad-
juvant in vivo. Importantly, our preliminary data indicated 
that the adjuvant effect of c-di-GMP depended on IRF3/7, 
as antibody responses in Irf3/7/ mice immunized with HSA 
and c-di-GMP were significantly (P < 0.05) reduced as com-
pared with immunized B6 mice (Fig. 6 C). Further studies 
will be required to establish the mechanism by which c-di-GMP 
functions as an adjuvant, but our results are consistent with 
a recent report indicating that the IRF3/7 kinase, TBK1, is 
required for adaptive immune responses in a DNA-vaccine 
model (Ishii et al., 2008).
DISCUSSION
It has been well established that innate immune responses are 
initiated in response to certain microbial ligands that are evo-
lutionarily conserved and that can be distinguished from self-
ligands. Nucleic acids appear to be a favored target of immune 
recognition, and are sensed by a variety of endosomal and 
cytosolic sensor proteins. The cyclic dinucleotide c-di-GMP 
is a bacterial second messenger that exhibits several character-
istics that are desirable in an immunostimulatory ligand: it is 
produced by numerous species of bacteria, it is a critical regu-
lator of bacterial physiology, and it is not similar to host mol-
ecules. Indeed, several previous reports have demonstrated 
that c-di-GMP can provoke potent immune responses when 
injected in vivo into mice (Karaolis et al., 2005a; Karaolis et al., 
2005b; Karaolis et al., 2007a; Karaolis et al., 2007b). How-
ever, the mechanism by which c-di-GMP stimulates immune 
responses remained unclear. Our data provide evidence that 
c-di-GMP is sensed by a novel cytosolic immunosurveillance 
pathway. Responsiveness to c-di-GMP is independent of TLRs 
that monitor the extracellular/endosomal compartments and 
is strongly potentiated by transfection of c-di-GMP into the 
host cell cytosol. Moreover, c-di-GMP provokes a transcrip-
tional response highly reminiscent of that triggered by the 
cytosolic presence of DNA or RNA, and involves activation 
of TBK-1, MAP kinases, and the IRF-3 and NF-B tran-
scription factors. Thus, we propose that c-di-GMP is sensed 
in the cytosol.
How many different cytosolic sensors exist for nucleic 
acids? Our data suggest that sensing of c-di-GMP occurs via 
a novel cytosolic immunosurveillance pathway. Known nu-
cleic acid sensors include Mda5 and RIG-I, which sense viral 
RNA and signal via MAVS, as well as DAI, a putative sensor 
of DNA that signals independently of MAVS. Based on the 
finding that most cell types, including MEFs, can still respond 
to DNA in the absence of DAI (Ishii et al., 2008), it has been 
proposed that an additional DNA sensor must exist and that 
MEFs express both of these sensors (Wang et al., 2008). Our 
results now suggest that there is at least one additional nucleic 
acid sensor in the cytosol, because we find that MEFs do not 1908 CYTOSOLIC SENSING OF cyclic-di-GMP | McWhirter et al.
B. Beutler (The Scripps Research Institute, La Jolla, CA), and RAW-B cells 
were obtained from G. Barton. Animal protocols were approved by the 
University of California, Berkeley Animal Care and Use Committee.
Reagents. c-di-GMP was synthesized as previously described (Kawai et al., 
2003), poly I:C was obtained from GE Biosciences, pdA:dT (poly(dA-dT):
poly(dA-dT)) was purchased from Sigma-Aldrich, ppGpp (guanosine-3,5-
bisdiphosphate) was obtained from TriLink Biotechnologies, pGpG (di-
guanosine) was purchased from IBA GmbH, GTP and cGMP were obtained 
from Sigma-Aldrich, purified LPS was purchased from InvivoGen, and Sendai 
virus was obtained from Charles River Laboratories. Theiler’s virus was the 
gift of M. Brahic (Stanford University, Stanford, CA).
Cell  culture. L929, RAW 264.7, and MEF cell lines were cultured in 
DMEM containing 10% FBS, glutamine, and penicillin-streptomycin. For 
bone marrow–derived macrophages, bone marrow cells from femurs and 
tibias were cultured for 7 d in RPMI 1640 media containing 10% FBS, glu-
tamine, penicillin-streptomycin, and10% CSF from 3T3 cells, with feeding 
on the fourth day of growth. For conventional dendritic cells (GM-CSF–
dendritic cells), bone marrow cells were cultured for 5 d with RPMI 1640 
containing 10% FBS, glutamine, penicillin-streptomycin, -mercaptoetha-
nol, and GM-CSF, with fresh media added on the second and fourth days of 
growth. Peritoneal macrophages were elicited by injection of 2 ml 4% thio-
glycollate (Fluid Thioglycollate Medium; BD), and were obtained 4 d later 
by lavage of the peritoneal cavity with RPMI 1640.
Cell  stimulations  (transfections).  Cells  were  transfected  using  Lipo-
fectamine 2000 (LF2000; Invitrogen) according to the manufacturer’s proto-
col. All nucleic acid stimulants were mixed with LF2000 at a ratio of 1 µl 
LF2000/1 µg nucleic acid, incubated at room temperature for 20–30 min, 
and added to cells at a final concentration of 3.3 µg/ml (96-well plates) or   
4 µg/ml (6-well plates). For pI:C, 2 mg/ml of the stock solution was heated 
at 50°C for 10 min and cooled to room temperature before mixing with 
LF2000. Transfection experiments were done for 6 h, unless otherwise stated 
in the figures. For phosphodiesterase treatment of c-di-GMP, 0.5 µg/µl c-di-
GMP was incubated for 2 h at room temperature in Optimem buffer (Invit-
rogen), with 15 mM MgCl2 and 1 U Phosphodiesterase I (GE Healthcare).
Quantitative PCR. Stimulated cells were overlayed with RNAlater (Ap-
plied Biosystems) and stored. RNA was isolated using the RNeasy kit 
(QIAGEN)  according  to  the  manufacturer’s  protocol,  and  was  treated 
with RQ1 RNase-free DNase (Promega). 0.5 µg RNA was reverse tran-
scribed with Superscript III (Invitrogen). Platinum Taq DNA polymerase (In-
vitrogen) and EvaGreen dye (Biotium) were used for quantitative PCR 
assays and analyzed with a real-time PCR system (StepOnePlus; Applied 
Biosystems). All gene expression values were normalized to Rps17 (mouse) 
or SP9 (human) levels for each sample. The following primer sequences 
were used: mouse Ifnb, (forward) 5-ATAAGCAGCTCCAGCTCCAA-3 
and (reverse) 5-CTGTCTGCTGGTGGAGTTCA-3; mouse Ifn5, (for-
ward) 5-TGACCTCAAAGCCTGTGTGATG-3 and (reverse) 5-AAG-
TATTTCCTCACAGCCAGCAG-3; mouse Rps17, (forward) 5-CGCC-
ATTATCCCCAGCAAG-3 and (reverse) 5-TGTCGGGATCCACC-
T CAATG-3;  human  IFN,  (forward)  5-AAACTCATGAGCAGTCT-
GCA-3  and  (reverse)  5-AGGAGATCTTCAGTTTCGGAGG-3;  and 
human  SP9,  (forward)  5-ATCCGCCAGCGCCATA-3  and  (reverse) 
5-TCAATGTGCTTCTGGGAATCC-3.
Type I IFN bioassay and luciferase reporter assay. Cell-culture super-
natants from stimulated cells were overlayed on top of ISRE-L929 IFN re-
porter cells (Jiang et al., 2005) and incubated for 4–6 h (96-well plate). The 
reporter cells were lysed in Passive Lysis Buffer (Promega) for 5 min at room 
temperature, mixed with firefly luciferin substrate (Biosynth), and measured 
on a luminometer (LmaxII384; MDS Analytical Technologies). Levels of 
type I IFN were calculated from a standard curve using recombinant mouse 
IFN- (R&D Systems).
secretion  system  of  F.  tularensis,  the  Dot/Icm  system  of   
L. pneumophila, or the MdrM multidrug efflux pump of   
L. monocytogenes. It is tempting to speculate that a small, bacte-
rially derived molecule such as c-di-GMP could be transported 
or leak through these secretion systems. It has not yet been 
possible to test this idea directly because all of these bacterial   
species encode numerous c-di-GMP synthases, and a strain 
lacking all c-di-GMP synthesis has not been reported. In any 
case, interpretation of these experiments would be compli-
cated by the fact that c-di-GMP plays important regulatory 
roles in bacterial physiology and pathogenesis. Nevertheless, 
our results with synthetic purified c-di-GMP suggest that in 
addition to DNA, c-di-GMP is a candidate for a conserved 
molecule unique to bacteria that is responsible for triggering 
transcription of type I IFN genes. In light of a recent report 
that bacteria appear to be able to synthesize c-di-AMP (Witte 
et al., 2008), it is interesting to consider whether additional 
nucleic acids produced specifically by bacteria might also trig-
ger host immunosurveillance pathways. Non–nucleic acid 
small molecules, such as the drug DMXAA, also appear to be 
able to stimulate the TBK1–IRF3 axis (Roberts et al., 2007). 
Indeed, there may be multiple redundant pathways for cyto-
solic sensing of bacteria. Collectively, the available evidence 
suggests that host cells may sense a wider array of bacterial li-
gands than was previously appreciated.
Our results may have important implications for the de-
sign of new adjuvants and vaccines. DNA vaccines have at-
tracted considerable enthusiasm as an approach for protecting 
against a variety of infectious diseases (Wang et al., 2001; 
Yang et al., 2004), but there are safety concerns about the in-
sertional mutagenic potential of DNA vaccines and/or their 
potential to trigger pathogenic anti-DNA autoimmune anti-
body responses (Schalk et al., 2006). The potency of DNA 
vaccines appears to derive from their ability to stimulate the 
TBK1 and innate cytosolic DNA-sensing pathways (Ishii et al., 
2006). Thus, our demonstration that a synthetic nonself non-
DNA molecule such as c-di-GMP can stimulate an in vitro 
and in vivo innate and adaptive immune response (Fig. 6) 
similar to that induced by DNA, without similar autoimmune 
or mutagenic risks, suggests that c-di-GMP might have valu-
able application as a small-molecule adjuvant. Understanding 
the molecular basis of c-di-GMP signaling in mammalian cells 
will be a crucial step toward achieving this aim.
MATERIALS AND METHODS
Mice and cell lines. Bone marrow macrophages were derived from various 
mouse strains, including Mavs/ (Sun et al., 2006), Mda5/ (Gitlin et al., 
2006), and Zbp1/ (Ishii et al., 2008). Wild-type C57BL/6 and Tnfr1/mice 
were from the Jackson Laboratory. Myd88//Trif /mice were obtained 
from G. Barton (University of California, Berkeley, Berkeley, CA). Irf1/, 
Irf3/, Irf5/, and Irf7/ mice were obtained from T. Taniguchi (Uni-
versity of Tokyo, Tokyo, Japan). Tbk1//Tnfr1/ mice were generated by 
crossing Tbk1/ mice (provided by W.-C. Yeh, University of Toronto, 
Toronto, Canada) with Tnfr1/mice. Rip2/ mice were obtained from   
R. Medzhitov (Yale University, New Haven, CT). Nod1//Nod2/ mice 
were obtained from D. Portnoy (University of California, Berkeley, Berke-
ley, CA). Nalp3/ mice were obtained from V. Dixit (Genentech, South 
San Francisco, CA). ISRE-L929 IFN reporter cells were obtained from   JEM VOL. 206, August 31, 2009 
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